Latest News

Higher Daily Step Count Linked to Lower Risk for Depression Among Adults / Image credit: ©lzf/AdobeStock
Higher Daily Step Count Linked to Lower Risk for Depression Among Adults

January 2nd 2025

Daily step counts of 5000 or more corresponded with fewer depressive symptoms, according to a recent systematic review and meta-analysis.

Women at higher risk for PTSD than men, according to large twin-sibling study / image credit ©Microgen/stock.adobe.com
Women are at Higher Genetic Risk for PTSD than Men, According to Large Twin-Sibling Study

December 19th 2024

Brexpiprazole and Sertraline Combination Therapy Shows Efficacy in Treating PTSD
Brexpiprazole and Sertraline Combination Therapy Shows Efficacy in Treating PTSD

December 18th 2024

FDA Review Sought for Lumateperone as Adjunctive Therapy for Major Depressive Disorder / Image credit: ©Kittiphan/AdobeStock
FDA Review Sought for Lumateperone as Adjunctive Therapy for Major Depressive Disorder

December 13th 2024

Most US Adults Want Primary Care Physicians to Address Mental Health: Daily Dose/ image credit: ©New Africa/AdobeStock
Most US Adults Want Primary Care Physicians to Address Mental Health: Daily Dose

December 11th 2024

Video Interviews
Latest CME Events & Activities

Real Psychiatry 2025

January 17 - 18, 2025

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

Southern California Psychiatry Conference

July 11-12, 2025

Register Now!

SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era

View More

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

View More

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

View More

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

View More

Clinical ShowCase: Developing a Personalized Treatment Plan for a Patient with Huntington’s Disease Associated Chorea

View More

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

View More

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

View More

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

View More

More News

© 2025 MJH Life Sciences

All rights reserved.